Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 21 for “"Metastatic recurrence"”.

  1. Two-Photon Imaging for Characterizing Tumor Microenvironmental Changes in Non-Small Cell Lung Cancer Associated with Metastatic Recurrence

    … that over half present with locally advanced or metastatic disease at time of diagnosis, and experience tumor recurrence following therapeutic intervention (Tamura et al., 2015; Uramoto & Tanaka, 2014). Current evaluation techniques to assess treatment response are lacking, given they are …

    arkansas Repository record for Two-Photon Imaging for Characterizing Tumor Microenvironmental Changes in Non-Small Cell Lung Cancer Associated with Metastatic Recurrence (opens in a new tab)

  2. Biomaterial Platforms to Study Cancer Dormancy and Develop Therapeutic Strategies for Breast and Ovarian Cancers

    … to be cancer-free after initial treatment, metastatic recurrence after months or years of asymptomatic latency period in patients is common in both cancers. Cancer cells that stay dormant and evade chemotherapy have been thought to underpin the metastatic recurrence, but the underlying …

    umn Repository record for Biomaterial Platforms to Study Cancer Dormancy and Develop Therapeutic Strategies for Breast and Ovarian Cancers (opens in a new tab)

  3. Tumor Nerve Innervation in Breast Cancer- Will it Serve as a prognostic indicator?

    … patient’s clinical parameters, such as metastatic recurrence, overall survival, and disease progression to triple-negative breast cancer. The tumor samples were procured from the Alberta Cancer Research Biobank. The sample cohort contained 19 and 17 primary breast tumors from patients …

    sask Repository record for Tumor Nerve Innervation in Breast Cancer- Will it Serve as a prognostic indicator? (opens in a new tab)

  4. Transcriptomic subtyping of prostate cancer

    … in prostate cancer are high, there is a risk of metastatic recurrence following primary treatment. Currently, there is no molecular subtyping system that is universally accepted and commonly implemented in the treatment of prostate cancer. The primary hypothesis of this research is that there are …

    qu-belfast Repository record for Transcriptomic subtyping of prostate cancer (opens in a new tab) Embargoed until 2027-12-31

  5. Turning Up Antitumor Immunity Against Breast Cancer

    … of localized disease is often successful, metastatic breast cancer, especially of the triple negative molecular subtype, carries a much poorer prognosis. The significant role of the immune system in the progression from localized to metastatic disease is becoming more and more appreciated. …

    south-carolina Repository record for Turning Up Antitumor Immunity Against Breast Cancer (opens in a new tab)

  6. Clinical Utility of the AJCC 8th Edition pT1 Subclassification and Impact on Practice Patterns in Stage I Seminoma

    … pT1b). The efficacy of this cutoff in predicting metastatic disease and impact on treatment patterns have not been studied. METHODS: We retrospectively reviewed patients with pT1 testicular seminoma in the National Cancer Database from 2004-2016. Receiver operating curves (ROC) were used to …

    utswmed Repository record for Clinical Utility of the AJCC 8th Edition pT1 Subclassification and Impact on Practice Patterns in Stage I Seminoma (opens in a new tab)

  7. Molecular interactions and signaling mechanisms of the oncogenic fusion protein DNAJ-PKAc in fibrolamellar carcinoma

    … increased levels of BAG2 in primary tumors and metastatic recurrence. BAG2 is linked to the anti-apoptotic factor Bcl-2. Pharmacological approaches using the DNA damaging agent etoposide and the Bcl-2 inhibitor navitoclax show that the DNAJ-PKAc/Hsp70/BAG2 axis contributes to chemotherapeutic …

    washington Repository record for Molecular interactions and signaling mechanisms of the oncogenic fusion protein DNAJ-PKAc in fibrolamellar carcinoma (opens in a new tab)

  8. Human cerebellar organoids as an in vitro 3D model of Group 3 Medulloblastoma

    … from each other for diagnosis, prognosis, and metastatic recurrence. WNT subtype has the best prognosis; SHH subtype has an intermediate prognosis; Group 3 subtype is characterized by a high percentage of metastases and worst prognosis; Group 4 MB is the most common subtype, but the less …

    trento Repository record for Human cerebellar organoids as an in vitro 3D model of Group 3 Medulloblastoma (opens in a new tab)

  9. GENETIC ALTERATIONS IN PROSTATE CANCER: EVALUATING THEIR BIOMARKER POTENTIAL AND ROLES IN THERAPEUTIC RESPONSE AND RESISTANCE

    … men due to the subset of patients who develop metastatic disease. In spite of recent advances, two substantial clinical challenges remain today: identifying who is at risk for (1) metastatic recurrence and (2) developing resistance to current therapies. In order to address these two main …

    jhu Repository record for GENETIC ALTERATIONS IN PROSTATE CANCER: EVALUATING THEIR BIOMARKER POTENTIAL AND ROLES IN THERAPEUTIC RESPONSE AND RESISTANCE (opens in a new tab)

  10. The Genomic Evolution Of Breast Cancer Metastasis

    … 1: Nearly all breast cancer deaths result from metastatic disease. Despite this, the genomic events that drive metastatic recurrence are poorly understood. Whole-exome and shallow whole-genome sequencing were employed to identify genes and pathways preferentially mutated or copy-number altered …

    penn Repository record for The Genomic Evolution Of Breast Cancer Metastasis (opens in a new tab)

  11. ELUCIDATING THE ROLE OF PTEN AND THE FOCAL ADHESION PATHWAY IN BREAST CANCER DORMANCY

    … breast cancer related deaths are the result of metastatic recurrence. The long latencies between initial primary tumor treatment and detection of recurrent disease suggest that surviving residual tumor cells pass through a state of dormancy. The tumor suppressor PTEN is associated with poor …

    penn Repository record for ELUCIDATING THE ROLE OF PTEN AND THE FOCAL ADHESION PATHWAY IN BREAST CANCER DORMANCY (opens in a new tab)

  12. Identification of Metastasis-Related Gene Signatures and the Role of PRLR Signaling in Breast Cancer Metastasis

    … diagnosed malignancies in women worldwide, and metastatic progression is the leading cause of cancer-related mortality. Although advances in treatment have improved long-term survival in breast cancer patients, the early prognosis of metastatic disease remains poor. A major limitation in …

    calgary Repository record for Identification of Metastasis-Related Gene Signatures and the Role of PRLR Signaling in Breast Cancer Metastasis (opens in a new tab)

  13. Therapeutic targeting of metastatic recurrences of pediatric medulloblastoma by selective kinase and histone deacetylase inhibitors

    … prognosis due to their high incidence of tumour recurrence and metastasis to the spinal leptomeninges. Relapsed Group 3 MB patients, particularly those with MYC amplification (known as Group 3𝛾), carry a mortality rate of nearly 100%, given the paucity of effective therapeutic options currently …

    mcmaster Repository record for Therapeutic targeting of metastatic recurrences of pediatric medulloblastoma by selective kinase and histone deacetylase inhibitors (opens in a new tab)

  14. Heterogeneity of Tumor-Infiltrating CD8+ T Cells: Implications for Systemic Immunity and Therapy

    … is severely compromised in cancer. Notably, metastatic disease, rather than primary tumors, accounts for the majority of cancer-related mortality. Persistent antigen exposure within the tumor microenvironment promotes T cell exhaustion and tissue residency, impairing their ability to mount …

    duke Repository record for Heterogeneity of Tumor-Infiltrating CD8+ T Cells: Implications for Systemic Immunity and Therapy (opens in a new tab) Embargoed until 2027-05-19

  15. Regression-based deep learning for weakly-supervised cancer biomarker prediction from whole-slide images

    … framework is applied to predict the Oncotype DX recurrence score (ODXRS), a standard-of-care genomic test for hormone receptor-positive early breast cancer, directly from routine histology slides. The resulting model, Orpheus, demonstrated superior prognostic utility by identifying patients at …

    qucosa-diss

Page 1 of 2